Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Embed Code Disclaimer Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Latest articles The Disruptors Reel TheDisruptors February 24, 2025 Northpointe Bank (NYSE: NPB) celebrates going public & vision for future growth Daily Download February 21, 2025 Block earnings, ESG support, OpenAI growth, Meta bonuses Daily Headlines February 21, 2025 Investors digest inflation concerns & Walmart reports earnings | Peter Tuchman, Senior Floor Trader @ Trademas | Market Movers: The Opening Bell February 21, 2025 Related articles The Disruptors Reel TheDisruptors February 24, 2025 Northpointe Bank (NYSE: NPB) celebrates going public & vision for future growth Daily Download February 21, 2025 Block earnings, ESG support, OpenAI growth, Meta bonuses Daily Headlines February 21, 2025